Employment of IFN-beta and the p53/Arf pathway for the development of a new immunotherapy for melanoma

• Grant number: 10/03958-2
• Support Opportunities: Scholarships in Brazil - Master
• Start date: August 01, 2010
• End date: June 30, 2012
• Field of knowledge: Biological Sciences - Microbiology - Applied Microbiology
• Principal Investigator: Bryan Eric Strauss
• Grantee: Ruan Felipe Vieira Medrano
• Host Institution: Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

MERKEL, C. A.; MEDRANO, R. F. V.; BARAUNA, V. G.; STRAUSS, B. E.. Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo. Cancer Gene Therapy, v. 20, n. 5, p. 317-325, MAY 2013. (10/03958-2)

BAJGELMAN, MARCIO C.; MEDRANO, RUAN F. V.; CARVALHO, ANNA CAROLINA P. V.; STRAUSS, BRYAN E.. AAVPG: A vigilant vector where transgene expression is induced by p53. VIROLOGY, v. 447, n. 1-2, p. 166-171, DEC 2013. (10/03958-2)

Academic Publications

(References retrieved automatically from State of São Paulo Research Institutions)

MEDRANO, Ruan Felipe Vieira. Investigation of the antitumor immune response induced by B16F10 cells treated with the p19Arf and Interferon-beta combination in a murine prophylatic model of melanoma vaccine. 2013. Master's Dissertation - Universidade de São Paulo (USP). Faculdade de Medicina (FM/SBD) São Paulo.